Quick answer
Zurich Biotech ships lyophilized research peptides to all Surabaya addresses and surrounding East Java cities, typically within one to two business days. Surabaya's Tanjung Perak port complex and the pharmaceutical cold-chain infrastructure in the Rungkut industrial district make the city Indonesia's primary distribution gateway for Eastern Indonesia. BPOM Regulation No. 27 of 2022 (as amended by Regulation No. 8 of 2024) governs research-use imports of unregistered pharmaceuticals through the Special Access Scheme, and that framework applies to research peptides shipped to any address in Indonesia, including Surabaya.
BPOM and the regulatory framework for research imports
BPOM (Badan Pengawas Obat dan Makanan) is Indonesia's national authority for drug and food oversight. Any pharmaceutical product without a domestic Marketing Authorization must enter through a licensed channel. For research purposes, that channel is the Special Access Scheme (SAS), which covers research, clinical development, and non-commercial scientific use.
Research peptides are not classified as narcotics or psychotropics under Indonesian law, so they follow the standard SAS pathway rather than any more restrictive route. BPOM Regulation No. 8 of 2024, issued alongside Government Regulation No. 28 of 2024 implementing Law No. 17 of 2023 on Health, introduced a digital processing track for SAS authorizations, reducing administrative turnaround for research-use imports.
For a researcher receiving a shipment at a Surabaya address, the SAS authorization sits with the importing entity, not the individual. The researcher takes delivery of a research-use compound already covered by that authorization. Orders ship with a Certificate of Analysis; the COA guide covers what to check on receipt.
Shipping to Surabaya and East Java
Tanjung Perak, Surabaya's port complex in North Surabaya, handled approximately 3.89 million TEU in 2024, placing it second in Indonesia by container volume and first for Eastern Indonesian trade. Cold-chain warehouse operators committed IDR 800 billion to pharmaceutical-grade expansion in the Rungkut industrial district between 2023 and 2025, expanding refrigerated and frozen storage capacity available to domestic pharmaceutical distributors.
Next-day delivery covers all five Surabaya municipal districts. South Surabaya (Darmo, Jemursari, Wonokromo, Gayungan, Wiyung) is a concentration of private clinic facilities; Central Surabaya (Genteng, Bubutan, Tegalsari) includes the central business district; East Surabaya (Sukolilo, Gubeng, Rungkut, the MERR corridor) holds both the UNAIR Kampus C campus and most pharmaceutical cold-chain warehouses; West Surabaya (Citraland, Pakuwon City, Tandes) has grown as a residential research hub; and North Surabaya (Kenjeran, Bulak, Pabean Cantian) sits closest to the Tanjung Perak port logistics corridor.
Cities in Greater Surabaya (Gerbangkertosusila) also fall within reliable delivery windows. Sidoarjo, directly south, and Gresik, north along the Java coast, receive orders within one business day. Mojokerto, 50 km to the west, is the same. Malang and the broader Malang Raya area, 90 km south through the Porong corridor, receive orders within two business days. Residential addresses, clinic complexes, apartment towers, and university research facilities all work with standard courier procedures.
Climate and storage in Surabaya
Surabaya falls in ICH Climatic Zone IVb, the hot-and-very-humid classification that sets pharmaceutical stability testing conditions at 30°C and 75% relative humidity. The city's annual mean temperature is 27.4°C. Peak dry-season temperatures reach 33 to 34°C between August and October. Relative humidity averages 78% year-round, dropping to about 68% in the dry months and rising above 80% through the November-to-April wet season.
Lyophilized peptides absorb moisture when exposed to ambient air under these conditions. A 2015 stability study published in the International Journal of Pharmaceutics (Srinivasan et al., Int J Pharm 2015) measured a 20 to 27% decrease in peptide concentration at 25°C and 60% relative humidity over 8 weeks, with measurable particulate formation in reconstituted samples. Surabaya's ambient conditions exceed both of those test parameters for most of the year.
Lyophilized vials should go into a freezer at -20°C or colder on receipt. A consensus on peptide handling and storage published in Clinical Chemistry (Hoofnagle et al., multi-site consortium, Clin Chem 2016) recommends -20°C storage and limiting freeze-thaw cycles to preserve compound integrity. A standard household or lab freezer at -18°C meets this requirement for most compounds over a 6 to 12-month research window.
Reconstituted peptide goes into the refrigerator at 2 to 8°C and should not sit at room temperature between uses. Power supply in central Surabaya and the Rungkut industrial zone is generally reliable, though parts of West Surabaya and outer residential areas experience occasional grid fluctuations during peak-demand months. A small UPS on the research freezer covers brief outages without requiring generator infrastructure. A full storage protocol, including freeze-thaw limits, desiccant handling, and compound-specific guidance, is in the article on lyophilized peptide storage in tropical climates.
Research environment in Surabaya
Universitas Airlangga (UNAIR), founded in 1954 on the central Dharmawangsa campus, is Indonesia's fourth-ranked public university by research output and one of the most-cited health sciences institutions in Southeast Asia. The Faculty of Pharmacy (Fakultas Farmasi UNAIR) has published more than 8,200 indexed articles with an h-index of 38 across its research portfolio. Active programs include pharmaceutical formulation and stability, pharmacokinetics, and natural products drug discovery. The Faculty of Medicine occupies the adjacent Kampus B campus, with clinical research anchored at RSUD Dr. Soetomo, East Java's primary national referral hospital, on the same site.
Institut Teknologi Sepuluh Nopember (ITS) on the Sukolilo campus in East Surabaya contributes bioengineering and analytical chemistry research, with several groups publishing in protein characterization and biosensor development. The geographic concentration of UNAIR's Kampus C and ITS in the Sukolilo district makes East Surabaya the city's primary academic science corridor.
South Surabaya, along the Jemursari and Darmo medical corridors, holds a cluster of private research clinics running investigational protocols in metabolic medicine, tissue recovery, and dermatology. These facilities represent a distinct demand segment from the university sector, with shorter protocol cycles and a higher proportion of single-compound research orders.
Research peptides ordered in Surabaya
BPC-157 and TB-500 together account for the largest share of vials shipped to Surabaya addresses, consistent with their position across Indonesia. The tissue repair profile of these compounds draws both academic researchers affiliated with UNAIR's medical and pharmacy faculties and private clinic operators running investigational recovery protocols. Surabaya's sporting culture, with active futsal, martial arts, and athletics communities, also generates demand for recovery-focused research compounds beyond the pure clinical sector.
Metabolic peptides, particularly Retatrutide (the triple GLP-1/GIP/glucagon agonist currently in Phase 3 trials) and GHK-Cu, make up the second-largest volume category. GHK-Cu orders come from both independent dermatology researchers and the South Surabaya clinic corridor. MOTS-c orders are a growing segment among researchers in UNAIR's biochemistry and physiology departments, where mitochondrial metabolism is an active research area.
For dosing calculations on any compound, the peptide dosing calculator handles reconstitution math for all standard vial concentrations and U-100 syringe measurements.